Fig. 4

Mice infected with S. aureus MRSA strain NRS315 and treated with vancomycin (110 mg twice daily) and compounds 4 and 5. ns = not significant,**p < 0.005 (two-way ANOVA). Figure adapted from PCT WO 2022204499
Mice infected with S. aureus MRSA strain NRS315 and treated with vancomycin (110 mg twice daily) and compounds 4 and 5. ns = not significant,**p < 0.005 (two-way ANOVA). Figure adapted from PCT WO 2022204499